Evidence map›Paper›PMID 29147805›Full record

ArticleEuropean journal of clinical pharmacology2018

Can clinical practice indicator relating to long-acting benzodiazepine use in the elderly be easily generated in a hospital setting?

Badria Kadri, Antonio Teixeira, Christelle Duteil, Annabelle Tan, Hélène Barreteau, Christophe Segouin, Pénélope Troude

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 78% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Badria KadriPublic Health and Health Economics Department, AP-HP, Saint-Louis-Lariboisière Fernand-Widal Hospital Group, Paris, France. badria.kadri@aphp.fr.ORCID http://orcid.org/0000-0002-7464-3848
Antonio TeixeiraGeriatric Department, AP-HP, Saint-Louis-Lariboisière Fernand-Widal Hospital Group, Paris, France.
Christelle DuteilPublic Health and Health Economics Department, AP-HP, Saint-Louis-Lariboisière Fernand-Widal Hospital Group, Paris, France.
Annabelle TanGeriatric Department, AP-HP, Saint-Louis-Lariboisière Fernand-Widal Hospital Group, Paris, France.
Hélène BarreteauPharmacy, AP-HP, Saint-Louis-Lariboisière Fernand-Widal Hospital Group, Paris, France.
Christophe SegouinPublic Health and Health Economics Department, AP-HP, Saint-Louis-Lariboisière Fernand-Widal Hospital Group, Paris, France.
Pénélope TroudePublic Health and Health Economics Department, AP-HP, Saint-Louis-Lariboisière Fernand-Widal Hospital Group, Paris, France.
Assistance Publique – Hôpitaux de Paris · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo improve the appropriate use of long-acting benzodiazepine (la.bzd) prescriptions in the elderly, the Haute Autorité de Santé (HAS) has developed clinical practice indicators (CPI). The alert indicator (AI) evaluates the prevalence of la.bzd prescription among older people. The mastering indicator (MI) corresponds to the prevalence of elderly with a justified, i.e., appropriate, la.bzd prescription among all the elderly with la.bzd prescriptions.

objectiveThe objective of this study was to test the feasibility of routine generation of CPI regarding la.bzd prescriptions among the elderly in the hospital setting.

designThis was a retrospective study.

settingThe study was conducted in two university hospitals located in Paris. SUBJECT: Eligible cases were patients aged 65 years and older who were hospitalized in acute care units from January to June 2014.

methodThe AI calculation was based on information extracted from medical databases from these hospitals. The appropriateness of la.bzd prescription was assessed by a physician and a pharmacist and was based on review of computerized patient records and prescriptions, using an ad hoc algorithm. The MI was then calculated. Variation in the level of indicators was explored according to the characteristics of patients and of their hospitalization using chi

resultAmong the 4167 patients included in the study, 362 had la.bzd prescriptions, i.e., the AI was 9%. Prescriptions were found to be appropriate for 83 patients, i.e., the MI was 23% and PIP was 77%. The MI varied between 13 and 31% according to characteristics of patients and of hospitalization. In multivariate analysis, factors associated with PIP were age, number of comorbidities, type of care unit, and concurrent prescription of a neuroleptic or hypnotic.

conclusionGeneration of the AI was routinely possible but only for acute care units with computerized prescriptions, corresponding to 78% of patients. Production of the MI has required medical record review for all patients with a la.bzd prescription and cannot be automated. However, difficulties in generating the MI have identified areas for significant improvement. Moreover, strategies to improve the care of older people with a la.bzd prescription could be targeted using characteristics of patients and of hospitalization associated with PIP. The future deployment of a single electronic medical record in all care departments would make it easier to mine the data and make possible automated production of CPI.

Indexed as

Guidelines as TopicAgedAged, 80 and overBenzodiazepinesDelayed-Action PreparationsFeasibility StudiesFemaleHumansInappropriate PrescribingMaleMedical Order Entry SystemsRetrospective StudiesBenzodiazepinesDelayed-Action PreparationsClinical practice indicatorLong acting benzodiazepineOlder peoplePotentially inappropriate prescription

Identifiers

PMID29147805
OpenAlexW2768848036

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.